Ch. 1 Pediatric Heath Supervision Flashcards
Normal Growth
Rules of Thumb for Expected Increase in Weight
Rules of Thumb for Expected Increase in Height
Growth Disturbances = growth outside usual pattern
Two common types & their causes:
-
Failure to thrive (FTT) = growth rate of less than expected for a child
- Concerning with child’s weight crosses two major isobars on National Health Statistics charts
- May involve all growth parameters (weight*, height, head circumference [until 2 y/o], sexual maturity)
- Order of affected: weight, length, head circumference
-
Most common cause of FTT:
-
Inorganic FTT (i.e., disturbed parent-child bond that results in inadequate caloric intake/retention)
- Poor formula preparation, poor feeding techniques, child abuse, maternal depression, alcohol/drug use, mental illness, family violence, poverty, isolation from support systems
-
Organic etiologies: underlying organ system pathology, infection, chromosomal disorders, systemic illness
- Determine timing of FTT (i.e., prenatal onset [intrauterine growth retardation] vs. postnatal onset of inadequate weight gain)
-
Inorganic FTT (i.e., disturbed parent-child bond that results in inadequate caloric intake/retention)
-
Head Growth Abnormalities = Microcephaly, craniosynostosis, macrocephaly
- General concepts:
-
Almost all head growth occurs prenatally and during first 2 years of life
- Head circumference at birth is 25% of normal adult head size and increases to 75% of normal adult head size by 1 year of age
- Scalp edema (cephalohematoma) [subperiosteal hemorrhage of newborn cranium after traumatic delivery] may interfere with accurate head circumference measurements
-
Almost all head growth occurs prenatally and during first 2 years of life
- General concepts:
Head Growth Abnormalities:
Microcephaly
Craniosynostosis
Plagiocephaly
Macrocephaly
Microcephaly
- Head circumference is 2-3 SDs below mean for age
- Incidence is 1-2/1000 children (0.01%)
- Etiologies:
- Congenital: abnormal induction and migration of brain tissue
- TORCH (Toxoplasmosis, other-syphilis, rubella, CMV, HSV)
- In utero exposure to drugs and toxins
- Chromosomal abnormalities
- Acquired: cerebral insult in late 3rd trimester, perinatal period, or 1 y/o
- Congenital: abnormal induction and migration of brain tissue
- Clinical Features:
- Because head size generally reflects brain size, microcephaly is always associated with a small brain –> developmental delay + intellectual impairment
- May be associated with: cerebral palsy/seizures
Craniosynostosis
- Premature closure of one or more of the cranial sutures
- Etiology: unknown (80-90% cases = sporadic)
- Risk factors:
- Intrauterine constraint
- Crowding
- Metabolic abnormalities
- Hyperthyroidism
- Hypercalcemia
- Clinical Features:
- Cranial sutures remain open until cessation of brain growth, which is 90% completed by age 2 and complete by age 5
- Diagnosis is made by physical exam of head –> usually noted by 6 mo of age / confirmed by skull radiographs and head CT scan
- Mgmt = surgical repair
Plagiocephaly = “flat head syndrome”
- Asymmetry of the infant head shape usually not associated with premature suture closure
- Most common type: positional plagiocephaly –> associated with flattening of the occiput and prominence of ipsilateral frontal area (viewed from the top, the skull is shaped like a parallelogram)
- May be associated with congenital muscular torticollis
- Mgmt: ROM exercises for associated torticollis, repositioning the head during sleep, helmet therapy, “tummy time”
Macrocephaly
- Head circumference > 95% for age
- Unlike microcephaly, size of head in patients with macrocephaly does not necessarily reflect brain size
- Etiologies:
- Familial
- Overgrowth syndromes (e.g., Sotos syndrome), in which all growth parameters are enlarged
- Metabolic storage disorders (e.g., Canavan syndrome, gangliosidoses)
- Neurofibromatosis
- Achondroplasia
- Hydrocephalus
- Space-occupying lesions
- Evaluation:
- Measure parenteral head circumferences and observe for split cranial sutures, bulging anterior fontanelle, irritability, vomiting (suggestive of inc. ICP)
- Head U/S or CT scan to r/o hydrocephalus
- Genetic eval if genetic syndrome suspected
Types of Immunizations
-
Active immunization
- Live vaccines:
- Long-lasting immunity, but carry risk of vaccine-associated disease in recipient
- Avoid in pts with compromised immunity (e.g., cancer, congenital or drug-induced immunodeficiencies)
- Examples: OPV; varicella; MMR
- Long-lasting immunity, but carry risk of vaccine-associated disease in recipient
- Non-live vaccines:
- Not infectious –> induce immunity for shorter periods –> thus, require boosters
- Examples: DTaP; hep A & B; inactivated polio (IPV); HIB; influenza; pneumococcal and meningococcal vaccines
- Live vaccines:
-
Passive immunization
- Delivery of preformed antibodies to individuals who have no active immunity against a particular disease but who have either been exposed to or are at high risk for exposure to infectious agent
- Examples:
- VZIG for immunocompromised pts who have been exposed to varicella and are high risk for severe varicella infection;
- Newborns born to hep B+ mothers receive hep B IG at birth;
- Visitors to high-risk areas receive hep A immune globulin before travel
Specific Immunizations:
Hep B Vaccine
Type?
Timing of vaccination?
Recombinant vaccine with particles of hep B surface antigen (HBsAg)
Timing: three-shot series within ~first year of life
- 1st dose HBV: Birth (within 12 hrs)
- 2nd dose: 1-2 mo.
- 3rd dose: 6-18 mo.
Specific Immunizations:
Diphtheria, tetanus, and acellular pertussis vaccine (DTaP)
Type?
Timing of vaccination?
DTaP vs. dT
Type? Inactivated
Timing?
- 3 dose primary series:
- 1st dose: 2 mo
- 2nd dose: 4 mo
- 3rd dose: 6 mo
- 2 dose secondary series:
- Booster 1: 12-18 mo
- Booster 2: 4-6 yr
dT (diphtheria and tetanus combined) contains 1/10th the dose of diphtheria toxoid and is recommended at age 11-12 and every 10 years thereafter
- Note that dT rather than DTaP is given to children > 7 y/o
Specific Immunizations:
Oral and inactivated polio vaccines (OPV/IPV)
Advantages? Disadvantages?
Timing?
-
Live attenuated (OPV), administered orally
- Advantage:
- Induction of both host immunity and secondary immunity b/c it is excreted in the stool of recipient and may infect, and thus immunize, close contacts (i.e., herd immunity)
- Disadvantage:
- Possibility of vaccine-related polio
- Advantage:
-
Non-live or inactivated (IPV), administered subcutaneously or IM
- Advantage:
- No vaccine-related polio
- Disadvantage:
- Does not induce secondary immunity
- Advantage:
Timing: In the U.S., only IPV is now recommended
- 1st dose: 2 mo.
- 2nd dose: 4 mo.
- Booster 1: 6-18 mo.
- Booster 2: 4-6 y/o.
Specific Immunizations:
HIB
Type of vaccine?
Timing of vaccination?
Type: conjugate vaccine with H. flu polysaccharide linked to various protein antigens, including diphtheria or tetanus toxoids, to augment immunogenicity
Timing of vaccination:
- Dose 1: 2 mo.
- Dose 2: 4 mo.
- Dose 3: 6 mo.
- Booster: 12-15 mo.
Specific Immunizations:
MMR
Type of vaccine?
Timing of vaccination?
- Measles: severe illness with complications that include pneumonia associated with significant mortality
- Mumps: commonly associated with parotitis but may also cause meningoencephalitis and orchitis
- Rubella: causes mild viral syndrome in children but may cause severe birth defects in offspring of susceptible women infected during pregnancy (TORCHeS)
Type of vaccine: live attenuated
Timing of vaccination: MMR recommended at 12-15 mo with a booster at either 4-6 years or 11-12 years of age
Specific immunizations:
Varicella vaccine
Type of vaccine?
Timing of vaccination?
Type of vaccine: live attenuated vaccine
Timing of vaccination:
- 1st dose: recommended at 12-18 mo
- 2nd dose: 4-6 yo
Specific Immunizations:
Hep A
Type of vaccine:
Timing of vaccination and recommendations:
Hep A
Type of vaccine: inactivated
Timing of vaccination and recommendations: 2 y/o + booster 6 mo. later for the following groups:
- Susceptible children living in communities with high hepatitis A rates & those traveling to endemic areas
- Individuals in other groups with high hep A rates: chronic liver disease, homosexual, bisexual men, drug users, pts with clotting factor disorders receiving blood products, pts at high risk for occupational exposure
Specific Immunizations:
Pneumococcal vaccines (Pneumovax and Prevnar)
Pneumovax: composed of polysaccharide capsular antigens from 23 pneumococcal serotypes
- Major advantage:
- Vaccine contains antigens from pneumococcal strains causing almost all cases of bacteremia and meningitis during childhood
- Major disadvantage:
- Vaccine has little immunogenicity in children younger than 2 y/o
- Indications:
- Vaccine is used primarily for older children and adults at high risk for pneumococcal disease (e.g., patients with sickle cell anemia who are functionally asplenic, immunodeficiency, chronic liver disease, and nephrotic syndrome)
Prevnar is composed of seven pneumococcal serotypes
- Major advantage:
- Immunogenicity and efficacy in preventing meningitis, pneumonia, bacteremia, and otitis media from the most common pneumococcal strains in children < 2 y/o
-
Major disadvantage:
- Does not confer broad coverage against pneumococcal strains as Pneumovax
- Indications:
- Vaccine recommended for all children younger than 2 y/o and for selected children older than 2 y/o who are at high risk for pneumococcal disease
- Prevnar is recommended at 2, 4, and 6 mo. with booster at 12-15 mo.
Adverse effects of immunization:
MMR and varicella
Both are live attenuated vaccines –> fever and rash may occur 1-2 weeks after immunization (i.e., after the incubation period of the virus)
Contraindications and precautions to immunization:
a. ____________ to a vaccine or its constituents
b. _____________ within 7 days after DTaP vaccine
c. _____________ patients should not receive OPV, MMR, and varicella vaccines.
d. _____________ patients should not receive live vaccines.
a. Anaphylaxis to a vaccine or its constituents
b. Encephalopathy within 7 days after DTaP vaccine
c. Immunodeficient patients should not receive OPV, MMR, and varicella vaccines.
d. Pregnant patients should not receive live vaccines.
Well Child Screening includes (8):
- Complete history and physical exam
- Growth measurements
- Blood pressure measurements
- Strabismus screening
- Vision screening for ophthalmologic disoders
- Hearing screening
- TB screening
- Laboratory screening
-
Neonatal Metabolic (State) Screening:
- congenital hypothyroidism
- PKU
- galactosemia (all can lead to irreversible brain injury)
-
Cholesterol and Lipid Screening:
- Recommended for children > age 2 with family hx of hypercholesterolemia, hyperlipidemia, or early MI
- Children with elevated cholesterol levels (75th-90th percentile) should have fasting lipid panel that includes total cholesterol, TGs, HDL, LDL
- Iron Deficiency Anemia Screening
- Urinalysis Screening
-
Lead Screening
- Children < 6 y/o most susceptible to effects of lead
-
Neonatal Metabolic (State) Screening: